H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Amyris (NASDAQ: AMRS) today and set a price target of $15. The company’s shares closed yesterday at $6.19.
According to TipRanks.com, Dayal is a 1-star analyst with an average return of 0.0% and a 41.3% success rate. Dayal covers the Consumer Goods sector, focusing on stocks such as Superconductor Technologies Inc, Pacific Ethanol, and Marrone Bio.
Amyris has an analyst consensus of Moderate Buy, with a price target consensus of $12.50.
See today’s analyst top recommended stocks >>
The company has a one-year high of $7.30 and a one-year low of $1.86. Currently, Amyris has an average volume of 693.9K.
Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Amyris, Inc. is an industrial biotechnology company, which engages in the provision of bioscience solutions. It focuses on the research, development, manufacture, and sale of fuels and farnesene-derived products. Its products include cosmetics, flavors and fragrances, performance materials, diesel, jet fuel, and lubricants. The company was founded by Jack D.
